Skip to main content
Top
Published in: Current Pulmonology Reports 1/2015

01-03-2015 | Sleeping and Breathing (T Lee-Chiong, Section Editor)

Sleep disorders in COPD

Authors: Sai Sunkara, Octavian C. Ioachimescu

Published in: Current Pulmonology Reports | Issue 1/2015

Login to get access

Abstract

In patients with chronic obstructive pulmonary disease (COPD, defined as a combination of emphysema and chronic bronchitis), sleep quality and architecture are often altered. The very common nocturnal symptoms of cough, dyspnea, chest tightness, and wheezing disturb sleep and lead to daytime dissatisfaction and additional symptoms in these patients. Sleep is often fragmented, while rapid eye movement sleep is generally diminished in duration. Due to nocturnal symptoms and possibly the use of certain medications, some patients with COPD experience difficulty initiating or maintaining sleep, symptoms that define insomnia. The known physiological changes that occur during sleep may have more profound consequences in COPD, such as persistent hypoxia and hypercapnia. The comorbid association of obstructive sleep apnea (OSA) and COPD (the “overlap syndrome”) may lead to more severe and persistent nocturnal hypoxemia and development of pulmonary hypertension, cor pulmonale, cardiac arrhythmia, and even sudden cardiac death. Diagnosing sleep abnormalities in patients with COPD is important, as it should address not only poorer sleep quality, but also co-existent sleep disordered breathing or other sleep conditions.
Literature
1.
go back to reference Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.CrossRefPubMed Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.CrossRefPubMed
2.
go back to reference Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994;154(15):1705–11.CrossRefPubMed Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994;154(15):1705–11.CrossRefPubMed
3.
go back to reference American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed.(ICSD-3): diagnostic and coding manual. Chicago: American Academy of Sleep Medicine; 2014. American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed.(ICSD-3): diagnostic and coding manual. Chicago: American Academy of Sleep Medicine; 2014.
4.
go back to reference Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term cae of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263–76.PubMed Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term cae of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263–76.PubMed
5.
6.
go back to reference Lopez PP, Stefan B, Schulman CI, Byers PM. Prevalence of sleep apnea in morbidly obese patients who presented for weight loss surgery evaluation: more evidence for routine screening for obstructive sleep apnea before weight loss surgery. Am Surg. 2008;74(9):834–8.PubMed Lopez PP, Stefan B, Schulman CI, Byers PM. Prevalence of sleep apnea in morbidly obese patients who presented for weight loss surgery evaluation: more evidence for routine screening for obstructive sleep apnea before weight loss surgery. Am Surg. 2008;74(9):834–8.PubMed
8.
go back to reference Agusti A, Hedner J, Marin JM, Barbe F, Cazzola M, Rennard S. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev Off J Eur Respir Soc. 2011;20(121):183–94.CrossRef Agusti A, Hedner J, Marin JM, Barbe F, Cazzola M, Rennard S. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev Off J Eur Respir Soc. 2011;20(121):183–94.CrossRef
9.
go back to reference Breslin E, van der Schans C, Breukink S, et al. Perception of fatigue and quality of life in patients with COPD. Chest. 1998;114(4):958–64.CrossRefPubMed Breslin E, van der Schans C, Breukink S, et al. Perception of fatigue and quality of life in patients with COPD. Chest. 1998;114(4):958–64.CrossRefPubMed
10.
go back to reference Cormick W, Olson LG, Hensley MJ, Saunders NA. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax. 1986;41(11):846–54.CrossRefPubMedCentralPubMed Cormick W, Olson LG, Hensley MJ, Saunders NA. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax. 1986;41(11):846–54.CrossRefPubMedCentralPubMed
11.
go back to reference Hedemark LL, Kronenberg RS. Ventilatory and heart rate responses to hypoxia and hypercapnia during sleep in adults. J Appl Physiol Respir Environ Exerc Physiol. 1982;53(2):307–12.PubMed Hedemark LL, Kronenberg RS. Ventilatory and heart rate responses to hypoxia and hypercapnia during sleep in adults. J Appl Physiol Respir Environ Exerc Physiol. 1982;53(2):307–12.PubMed
12.
go back to reference Goldstein RS, Ramcharan V, Bowes G, McNicholas WT, Bradley D, Phillipson EA. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med. 1984;310(7):425–9.CrossRefPubMed Goldstein RS, Ramcharan V, Bowes G, McNicholas WT, Bradley D, Phillipson EA. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med. 1984;310(7):425–9.CrossRefPubMed
13.
go back to reference Kwon JS, Wolfe LF, Lu BS, Kalhan R. Hyperinflation is associated with lower sleep efficiency in COPD with co-existent obstructive sleep apnea. COPD. 2009;6(6):441–5.CrossRefPubMed Kwon JS, Wolfe LF, Lu BS, Kalhan R. Hyperinflation is associated with lower sleep efficiency in COPD with co-existent obstructive sleep apnea. COPD. 2009;6(6):441–5.CrossRefPubMed
14.
go back to reference Budhiraja R, Parthasarathy S, Budhiraja P, Habib MP, Wendel C, Quan SF. Insomnia in patients with COPD. Sleep. 2012;35(3):369–75.PubMedCentralPubMed Budhiraja R, Parthasarathy S, Budhiraja P, Habib MP, Wendel C, Quan SF. Insomnia in patients with COPD. Sleep. 2012;35(3):369–75.PubMedCentralPubMed
15.
go back to reference Ohayon MM. Chronic obstructive pulmonary disease and its association with sleep and mental disorders in the general population. J Psychiatr Res. 2014;54:79–84.CrossRefPubMed Ohayon MM. Chronic obstructive pulmonary disease and its association with sleep and mental disorders in the general population. J Psychiatr Res. 2014;54:79–84.CrossRefPubMed
16.
go back to reference Klink M, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest. 1987;91(4):540–6.CrossRefPubMed Klink M, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest. 1987;91(4):540–6.CrossRefPubMed
17.
go back to reference Klink ME, Dodge R, Quan SF. The relation of sleep complaints to respiratory symptoms in a general population. Chest. 1994;105(1):151–4.CrossRefPubMed Klink ME, Dodge R, Quan SF. The relation of sleep complaints to respiratory symptoms in a general population. Chest. 1994;105(1):151–4.CrossRefPubMed
18.
go back to reference Miravitlles M, Worth H, Soler Cataluna J, et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res. 2014;15(1):122.CrossRefPubMedCentralPubMed Miravitlles M, Worth H, Soler Cataluna J, et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res. 2014;15(1):122.CrossRefPubMedCentralPubMed
19.
go back to reference Sanders MH, Newman AB, Haggerty CL, et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med. 2003;167(1):7–14.CrossRefPubMed Sanders MH, Newman AB, Haggerty CL, et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med. 2003;167(1):7–14.CrossRefPubMed
20.
go back to reference McSharry DG, Ryan S, Calverley P, Edwards JC, McNicholas WT. Sleep quality in chronic obstructive pulmonary disease. Respirology. 2012;17(7):1119–24.CrossRefPubMed McSharry DG, Ryan S, Calverley P, Edwards JC, McNicholas WT. Sleep quality in chronic obstructive pulmonary disease. Respirology. 2012;17(7):1119–24.CrossRefPubMed
21.
go back to reference Martinez CH, Kim V, Chen Y, et al. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med. 2014;108(3):491–9.CrossRefPubMedCentralPubMed Martinez CH, Kim V, Chen Y, et al. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med. 2014;108(3):491–9.CrossRefPubMedCentralPubMed
22.
go back to reference Saaresranta T, Irjala K, Aittokallio T, Polo O. Sleep quality, daytime sleepiness and fasting insulin levels in women with chronic obstructive pulmonary disease. Respir Med. 2005;99(7):856–63.CrossRefPubMed Saaresranta T, Irjala K, Aittokallio T, Polo O. Sleep quality, daytime sleepiness and fasting insulin levels in women with chronic obstructive pulmonary disease. Respir Med. 2005;99(7):856–63.CrossRefPubMed
23.
go back to reference Soler X, Diaz-Piedra C, Ries AL. Pulmonary rehabilitation improves sleep quality in chronic lung disease. COPD. 2013;10(2):156–63.CrossRefPubMed Soler X, Diaz-Piedra C, Ries AL. Pulmonary rehabilitation improves sleep quality in chronic lung disease. COPD. 2013;10(2):156–63.CrossRefPubMed
24.
go back to reference Buysse DJ, Reynolds 3rd CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed Buysse DJ, Reynolds 3rd CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed
25.
go back to reference Fanfulla F, Cascone L, Taurino AE. Sleep disordered breathing in patients with chronic obstructive pulmonary disease. Minerva Med. 2004;95(4):307–21.PubMed Fanfulla F, Cascone L, Taurino AE. Sleep disordered breathing in patients with chronic obstructive pulmonary disease. Minerva Med. 2004;95(4):307–21.PubMed
27.
28.
go back to reference McNicholas WT. Impact of sleep in respiratory failure. Eur Respir J. 1997;10(4):920–33.PubMed McNicholas WT. Impact of sleep in respiratory failure. Eur Respir J. 1997;10(4):920–33.PubMed
29.
go back to reference Trask CH, Cree EM. Oximeter studies on patients with chronic obstructive emphysema, awake and during sleep. N Engl J Med. 1962;266:639–42.CrossRefPubMed Trask CH, Cree EM. Oximeter studies on patients with chronic obstructive emphysema, awake and during sleep. N Engl J Med. 1962;266:639–42.CrossRefPubMed
30.
go back to reference Becker HF, Piper AJ, Flynn WE, et al. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med. 1999;159(1):112–8.CrossRefPubMed Becker HF, Piper AJ, Flynn WE, et al. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med. 1999;159(1):112–8.CrossRefPubMed
31.
go back to reference Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax. 2009;64(2):133–8.CrossRefPubMed Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax. 2009;64(2):133–8.CrossRefPubMed
32.
go back to reference Chaouat A, Weitzenblum E, Kessler R, et al. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J. 1997;10(8):1730–5.CrossRefPubMed Chaouat A, Weitzenblum E, Kessler R, et al. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J. 1997;10(8):1730–5.CrossRefPubMed
33.
go back to reference Johnson MW, Remmers JE. Accessory muscle activity during sleep in chronic obstructive pulmonary disease. J Appl Physiol. 1984;57(4):1011–7.PubMed Johnson MW, Remmers JE. Accessory muscle activity during sleep in chronic obstructive pulmonary disease. J Appl Physiol. 1984;57(4):1011–7.PubMed
34.
go back to reference Fletcher EC, Donner CF, Midgren B, et al. Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest. 1992;101(3):649–55.CrossRefPubMed Fletcher EC, Donner CF, Midgren B, et al. Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest. 1992;101(3):649–55.CrossRefPubMed
35.
go back to reference McNicholas WT, Fitzgerald MX. Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J. 1984;289(6449):878.CrossRef McNicholas WT, Fitzgerald MX. Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J. 1984;289(6449):878.CrossRef
36.
go back to reference Flenley DC. Sleep in chronic obstructive lung disease. Clin Chest Med. 1985;6(4):651–61.PubMed Flenley DC. Sleep in chronic obstructive lung disease. Clin Chest Med. 1985;6(4):651–61.PubMed
37.
go back to reference Bradley TD, Rutherford R, Grossman RF, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis. 1985;131(6):835–9.PubMed Bradley TD, Rutherford R, Grossman RF, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis. 1985;131(6):835–9.PubMed
38.
go back to reference Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest. 1996;109(2):380–6.CrossRefPubMed Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest. 1996;109(2):380–6.CrossRefPubMed
39.
go back to reference Bednarek M, Plywaczewski R, Jonczak L, Zielinski J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respir Int Rev Thorac Dis. 2005;72(2):142–9. Bednarek M, Plywaczewski R, Jonczak L, Zielinski J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respir Int Rev Thorac Dis. 2005;72(2):142–9.
40.
go back to reference Ioachimescu OC, Teodorescu M. Integrating the overlap of obstructive lung disease and obstructive sleep apnoea: OLDOSA syndrome. Respirology. 2013;18(3):421–31.CrossRefPubMed Ioachimescu OC, Teodorescu M. Integrating the overlap of obstructive lung disease and obstructive sleep apnoea: OLDOSA syndrome. Respirology. 2013;18(3):421–31.CrossRefPubMed
41.
go back to reference McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009;180(8):692–700.CrossRefPubMed McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009;180(8):692–700.CrossRefPubMed
42.
go back to reference Owens RL, Malhotra A. Sleep-disordered breathing and COPD: the overlap syndrome. Respir Care. 2010;55(10):1333–44. discussion 1344–1336.PubMedCentralPubMed Owens RL, Malhotra A. Sleep-disordered breathing and COPD: the overlap syndrome. Respir Care. 2010;55(10):1333–44. discussion 1344–1336.PubMedCentralPubMed
43.
go back to reference Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med. 1995;151(1):82–6.CrossRefPubMed Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med. 1995;151(1):82–6.CrossRefPubMed
44.
go back to reference Ioachimescu OC, Tanukonda V, Anderson AL, Ciavatta MM, McCarver K. Asthma, chronic obstructive pulmonary disease, obstructive sleep apnea and overlap syndromes in veteran patients—prevalence and outcomes. Am J Respir Crit Care Med. 2014;189. Ioachimescu OC, Tanukonda V, Anderson AL, Ciavatta MM, McCarver K. Asthma, chronic obstructive pulmonary disease, obstructive sleep apnea and overlap syndromes in veteran patients—prevalence and outcomes. Am J Respir Crit Care Med. 2014;189.
45.
go back to reference Mulloy E, McNicholas WT. Ventilation and gas exchange during sleep and exercise in severe COPD. Chest. 1996;109(2):387–94.CrossRefPubMed Mulloy E, McNicholas WT. Ventilation and gas exchange during sleep and exercise in severe COPD. Chest. 1996;109(2):387–94.CrossRefPubMed
46.
go back to reference Plywaczewski R, Sliwinski P, Nowinski A, Kaminski D, Zielinski J. Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing long-term oxygen therapy. Chest. 2000;117(3):679–83.CrossRefPubMed Plywaczewski R, Sliwinski P, Nowinski A, Kaminski D, Zielinski J. Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing long-term oxygen therapy. Chest. 2000;117(3):679–83.CrossRefPubMed
47.
go back to reference Mulloy E, Fitzpatrick M, Bourke S, O’Regan A, McNicholas WT. Oxygen desaturation during sleep and exercise in patients with severe chronic obstructive pulmonary disease. Respir Med. 1995;89(3):193–8.CrossRefPubMed Mulloy E, Fitzpatrick M, Bourke S, O’Regan A, McNicholas WT. Oxygen desaturation during sleep and exercise in patients with severe chronic obstructive pulmonary disease. Respir Med. 1995;89(3):193–8.CrossRefPubMed
48.
go back to reference Rasche K, Orth M, Kutscha A, Duchna HW. Pulmonary diseases and heart function. Internist (Berl). 2007;48(3):276–82.CrossRef Rasche K, Orth M, Kutscha A, Duchna HW. Pulmonary diseases and heart function. Internist (Berl). 2007;48(3):276–82.CrossRef
49.
go back to reference Machado MC, Vollmer WM, Togeiro SM, et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J. 2010;35(1):132–7.CrossRefPubMed Machado MC, Vollmer WM, Togeiro SM, et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J. 2010;35(1):132–7.CrossRefPubMed
50.
go back to reference Moloney ED, Kiely JL, McNicholas WT. Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease. Lancet. 2001;357(9255):526–8.CrossRefPubMed Moloney ED, Kiely JL, McNicholas WT. Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease. Lancet. 2001;357(9255):526–8.CrossRefPubMed
51.
go back to reference Loredo JS, Ancoli-Israel S, Kim EJ, Lim WJ, Dimsdale JE. Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. Sleep. 2006;29(4):564–71.PubMed Loredo JS, Ancoli-Israel S, Kim EJ, Lim WJ, Dimsdale JE. Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. Sleep. 2006;29(4):564–71.PubMed
52.
go back to reference Martin RJ, Bartelson BL, Smith P, et al. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest. 1999;115(5):1338–45.CrossRefPubMed Martin RJ, Bartelson BL, Smith P, et al. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest. 1999;115(5):1338–45.CrossRefPubMed
53.
go back to reference McNicholas WT, Calverley PM, Lee A, Edwards JC. Tiotropium sleep study in CI. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J. 2004;23(6):825–31.CrossRefPubMed McNicholas WT, Calverley PM, Lee A, Edwards JC. Tiotropium sleep study in CI. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J. 2004;23(6):825–31.CrossRefPubMed
54.
go back to reference Machado MC, Vollmer WM, Togeiro SM, et al. CPAP treatment and survival of patients with moderate-to-severe OSAS and hypoxemic COPD. Eur Respir J. 2009. Machado MC, Vollmer WM, Togeiro SM, et al. CPAP treatment and survival of patients with moderate-to-severe OSAS and hypoxemic COPD. Eur Respir J. 2009.
55.
go back to reference Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med. 2010;182(3):325–31.CrossRefPubMed Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med. 2010;182(3):325–31.CrossRefPubMed
56.
go back to reference Toraldo DM, De Nuccio F, Nicolardi G. Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study. Sleep Breath Schlaf Atmung. 2010;14(2):115–23.CrossRef Toraldo DM, De Nuccio F, Nicolardi G. Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study. Sleep Breath Schlaf Atmung. 2010;14(2):115–23.CrossRef
57.
go back to reference Jaoude P, Kufel T, El-Solh AA. Survival benefit of CPAP favors hypercapnic patients with the overlap syndrome. Lung. 2014;192(2):251–8.CrossRefPubMed Jaoude P, Kufel T, El-Solh AA. Survival benefit of CPAP favors hypercapnic patients with the overlap syndrome. Lung. 2014;192(2):251–8.CrossRefPubMed
58.
go back to reference Casanova C, Celli BR, Tost L, et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest. 2000;118(6):1582–90.CrossRefPubMed Casanova C, Celli BR, Tost L, et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest. 2000;118(6):1582–90.CrossRefPubMed
59.
go back to reference Clini E, Sturani C, Rossi A, et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J. 2002;20(3):529–38.CrossRefPubMed Clini E, Sturani C, Rossi A, et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J. 2002;20(3):529–38.CrossRefPubMed
60.
go back to reference Jones SE, Packham S, Hebden M, Smith AP. Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long-term follow up and effect on survival. Thorax. 1998;53(6):495–8.CrossRefPubMedCentralPubMed Jones SE, Packham S, Hebden M, Smith AP. Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long-term follow up and effect on survival. Thorax. 1998;53(6):495–8.CrossRefPubMedCentralPubMed
61.
go back to reference Budweiser S, Jorres RA, Riedl T, et al. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest. 2007;131(6):1650–8.CrossRefPubMed Budweiser S, Jorres RA, Riedl T, et al. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest. 2007;131(6):1650–8.CrossRefPubMed
62.
go back to reference McEvoy RD, Pierce RJ, Hillman D, et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax. 2009;64(7):561–6.CrossRefPubMed McEvoy RD, Pierce RJ, Hillman D, et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax. 2009;64(7):561–6.CrossRefPubMed
63.
go back to reference Tsolaki V, Pastaka C, Karetsi E, et al. One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life. Respir Med. 2008;102(6):904–11.CrossRefPubMed Tsolaki V, Pastaka C, Karetsi E, et al. One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life. Respir Med. 2008;102(6):904–11.CrossRefPubMed
64.
go back to reference Struik FM, Lacasse Y, Goldstein R, Kerstjens HM, Wijkstra PJ. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;6, CD002878.PubMed Struik FM, Lacasse Y, Goldstein R, Kerstjens HM, Wijkstra PJ. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;6, CD002878.PubMed
65.
go back to reference Struik FM, Lacasse Y, Goldstein RS, Kerstjens HA, Wijkstra PJ. Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis. Respir Med. 2014;108(2):329–37.CrossRefPubMed Struik FM, Lacasse Y, Goldstein RS, Kerstjens HA, Wijkstra PJ. Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis. Respir Med. 2014;108(2):329–37.CrossRefPubMed
66.
go back to reference Gay PC, Hubmayr RD, Stroetz RW. Efficacy of nocturnal nasal ventilation in stable, severe chronic obstructive pulmonary disease during a 3-month controlled trial. Mayo Clin Proc. 1996;71(6):533–42.CrossRefPubMed Gay PC, Hubmayr RD, Stroetz RW. Efficacy of nocturnal nasal ventilation in stable, severe chronic obstructive pulmonary disease during a 3-month controlled trial. Mayo Clin Proc. 1996;71(6):533–42.CrossRefPubMed
67.
go back to reference Meecham Jones DJ, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med. 1995;152(2):538–44.CrossRefPubMed Meecham Jones DJ, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med. 1995;152(2):538–44.CrossRefPubMed
68.
go back to reference Elliott MW, Mulvey DA, Moxham J, Green M, Branthwaite MA. Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions. Eur Respir J. 1991;4(9):1044–52.PubMed Elliott MW, Mulvey DA, Moxham J, Green M, Branthwaite MA. Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions. Eur Respir J. 1991;4(9):1044–52.PubMed
69.
go back to reference Goldstein RS, De Rosie JA, Avendano MA, Dolmage TE. Influence of noninvasive positive pressure ventilation on inspiratory muscles. Chest. 1991;99(2):408–15.CrossRefPubMed Goldstein RS, De Rosie JA, Avendano MA, Dolmage TE. Influence of noninvasive positive pressure ventilation on inspiratory muscles. Chest. 1991;99(2):408–15.CrossRefPubMed
70.
go back to reference Celli BR, MacNee W, Force AET. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–46.CrossRefPubMed Celli BR, MacNee W, Force AET. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–46.CrossRefPubMed
Metadata
Title
Sleep disorders in COPD
Authors
Sai Sunkara
Octavian C. Ioachimescu
Publication date
01-03-2015
Publisher
Springer US
Published in
Current Pulmonology Reports / Issue 1/2015
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-015-0107-7

Other articles of this Issue 1/2015

Current Pulmonology Reports 1/2015 Go to the issue

Sleeping and Breathing (T Lee-Chiong, Section Editor)

Obesity hypoventilation syndrome

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

Chemical pleurodesis for first presentation of primary spontaneous pneumothorax

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

IgG4-related pleural disease

Pleural Diseases and Mesothelioma (C Gary Lee, Section Editor)

Adjunct strategies to enhance the efficacy of indwelling pleural catheters

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

Discovery of new biomarkers for malignant mesothelioma

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.